Abstracts of Presentations from the 2020 Trans-Agency Scientific Meeting on Developing Medical Countermeasures to Treat the Acute and Chronic Effects of Ocular Chemical Toxicity, 25-26 February, Bethesda, Maryland.
作者信息
Yeung David T, Araj Houmam, McNutt Patrick M
机构信息
Department of Health and Human Services, National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIAID/NIH), 5601 Fishers Lane (1G58), Bethesda, MA, 20892, USA.
Department of Health and Human Services, National Eye Institute/National Institutes of Health (NEI/NIH), 6700B Rockledge Dr (Suite 3400), Bethesda, MA, 20817, USA.
出版信息
Toxicol Lett. 2020 May 25:1-3. doi: 10.1016/j.toxlet.2020.05.026.
Abstract
摘要
相似文献
1
Abstracts of Presentations from the 2020 Trans-Agency Scientific Meeting on Developing Medical Countermeasures to Treat the Acute and Chronic Effects of Ocular Chemical Toxicity, 25-26 February, Bethesda, Maryland.2020年2月25日至26日于马里兰州贝塞斯达召开的跨部门科学会议：眼部化学毒性急慢性影响医学应对措施研发成果报告摘要
Toxicol Lett. 2020 May 25:1-3. doi: 10.1016/j.toxlet.2020.05.026.
2
National Institutes of Health (NIH) Executive Meeting Summary: Developing Medical Countermeasures to Rescue Opioid-Induced Respiratory Depression (a Trans-Agency Scientific Meeting)-August 6/7, 2019.美国国立卫生研究院（NIH）执行会议摘要：制定医疗对策以挽救阿片类药物引起的呼吸抑制（跨机构科学会议）-2019 年 8 月 6/7 日。
J Med Toxicol. 2020 Jan;16(1):87-105. doi: 10.1007/s13181-019-00750-x. Epub 2019 Dec 18.
3
4
Abstracts of the Seventh Scientific Meeting of The TMJ Association, 7-9 September 2014, Bethesda, Maryland.颞下颌关节协会第七届科学会议摘要，2014年9月7日至9日，马里兰州贝塞斯达。
Mol Pain. 2014 Dec 12;10 Suppl 1(Suppl 1):O1-P6. doi: 10.1186/1744-8069-10-s1-o1.
5
16th Annual Scientific Meeting of the Society for Biological Therapy. 8 - 11 November 2001, Bethesda, Maryland, USA.生物治疗学会第16届年度科学会议。2001年11月8日至11日，美国马里兰州贝塞斯达。
Expert Opin Biol Ther. 2002 Feb;2(2):223-7. doi: 10.1517/14712598.2.2.223.
6
Countermeasures for Preventing and Treating Opioid Overdose.阿片类药物过量预防和治疗的对策。
Clin Pharmacol Ther. 2021 Mar;109(3):578-590. doi: 10.1002/cpt.2098. Epub 2020 Nov 29.
7
18th Annual Scientific Meeting of the International Society for Biological Therapy of Cancer. 30 October-2 November 2003, Bethesda, Maryland, USA.国际癌症生物治疗学会第18届年会。2003年10月30日至11月2日，美国马里兰州贝塞斯达。
Expert Opin Biol Ther. 2004 Jan;4(1):107-14. doi: 10.1517/14712598.4.1.107.
8
Considerations in developing medical countermeasures against chemical ocular toxicity.制定化学性眼部毒性医疗对策时需考虑的因素。
Toxicol Lett. 2020 Nov 1;334:1-3. doi: 10.1016/j.toxlet.2020.09.004. Epub 2020 Sep 8.
9
Rate and Predictors of Publication of Resident Abstracts Presented at Oman Medical Specialty Board Scientific Meetings.阿曼医学专业委员会科学会议上住院医师摘要的发表率及预测因素
Sultan Qaboos Univ Med J. 2018 Nov;18(4):e501-e506. doi: 10.18295/squmj.2018.18.04.012. Epub 2019 Mar 28.
10
Publication rate of paper and podium presentations from the European Section of the Cervical Spine Research Society Annual Meeting.颈椎研究协会年会欧洲分会的论文发表率及大会发言情况
Eur Spine J. 2016 Jul;25(7):2311-6. doi: 10.1007/s00586-016-4404-9. Epub 2016 Feb 11.
引用本文的文献
1
Ocular Surface - Merging Challenges and Opportunities.眼表——融合挑战与机遇
Transl Vis Sci Technol. 2020 Nov 2;9(12):3. doi: 10.1167/tvst.9.12.3. eCollection 2020 Nov.
2
Considerations in developing medical countermeasures against chemical ocular toxicity.制定化学性眼部毒性医疗对策时需考虑的因素。
Toxicol Lett. 2020 Nov 1;334:1-3. doi: 10.1016/j.toxlet.2020.09.004. Epub 2020 Sep 8.
本文引用的文献
1
Supporting Fundamental Chemical Toxicology Research To Inform Medical Countermeasure Developments: The National Institutes of Health Chemical Countermeasures Research Program.支持基础化学毒理学研究以指导医学对策开发：美国国立卫生研究院化学对策研究计划。
Chem Res Toxicol. 2020 Apr 20;33(4):855-859. doi: 10.1021/acs.chemrestox.0c00086. Epub 2020 Mar 20.
2
Office of the Assistant Secretary for Preparedness and Response; HHS Public Health Emergency Medical Countermeasures Enterprise implementation plan for chemical, biological, radiological and nuclear threats. Notice.应急准备与响应助理部长办公室；美国卫生与公众服务部针对化学、生物、放射和核威胁的公共卫生应急医疗对策企业实施计划。通知。
Fed Regist. 2007 Apr 23;72(77):20117-28.
Zotero 插件